Latest alli Stories

PARSIPPANY, N.J., Dec. 13, 2012 /PRNewswire/ -- GlaxoSmithKline Consumer Healthcare and TV Personality and busy mom of two, Samantha Harris, are pleased to announce the launch of Let's Fight Holiday Fat - a new, free online guide that provides weight maintenance support for Americans trying to squeeze in healthy eating and exercise this season. The tool, created courtesy of alli® - the first and only FDA-approved weight-loss aid available without a prescription - is for anyone...

Healthhound.org appoints a researcher to buy alli weight loss pills. He will be reporting back on his findings on the site in 3 months time. Houston, TX. (PRWEB) December 17, 2011 Healthhound.org has just appointed a researcher to buy alli weight loss pills and see how much weight he can lose. He will then report back to the health hound readers in 3 months how the experiment went. Readers who are thinking of investing in the pills are welcome to check in with the site at that stage and...

Healthhound.org is going to try the Alli weight loss pill. The management at the site have assembled a team that will be trying out the pill. Houston, TX. (PRWEB) December 15, 2011 Healthhound.org have just assembled a team that will be taking the Alli weight loss pill for the next 6 weeks and will be reporting back on their findings to readers. The management at the site want their readers to see what this pill can do first hand to a normal group of people with regard to weight loss....

LONDON, May 17, 2011 /PRNewswire/ -- - alli Research Exposes That Without Intervention Overweight People Could Face a Decade of Dieting, and Social Stigma About Their Weight Overweight Brits are in denial about their weight and continue to eat an unhealthy diet despite health warnings about obesity, according to new research by weight loss aid alli*. One in five (20%) overweight people[1] questioned in Britain said they have never tried to lose their excess weight at all....

PARSIPPANY, N.J., April 14, 2011 /PRNewswire/ -- GlaxoSmithKline (GSK) is committed to ensuring that consumers and physicians understand the safety profile of orlistat and alli. alli is safe and effective when used as directed. Orlistat is minimally absorbed in the blood and works locally in the gastro-intestinal tract. GSK continues to proactively monitor for the safety of orlistat and share all relevant information with regulatory agencies. Since orlistat first became available as a...

PALM BEACH, Fla., Feb. 21, 2011 /PRNewswire/ -- The NASCAR Camping World Truck Series event in Daytona was the backdrop for the filming of the Rue & Ziffra PA - Alli Owens Community Service Commercial produced by iCreative Network. A group of organizations, including Daytona's own Rue & Ziffra PA, sponsored Alli Owens for the race. Alli's social media sponsors, including Facebook and Twitter account for what may be the first time in history, fan donations helped put a NASCAR racer on...

LONDON, February 7, 2011 /PRNewswire/ -- GlaxoSmithKline (GSK) today announces that it has received a licence extension for alli, the first pharmacy-only weight loss aid licensed for use throughout Europe. This license extension is for new chewable tablets. The new alli tablets are planned to be on sale in pharmacies throughout the UK in April this year. alli is for overweight adults with a BMI of 28 or more and can help boost your weight loss compared with dieting alone. alli...

SAN DIEGO, June 14 /PRNewswire/ -- Sony today announced plans to sponsor the 2010 Dew Tour, a series of five events throughout the year featuring competition with some of the world's best skateboard, BMX and freestyle motocross athletes. Beginning in late June with the Skate Open, ISF(TM) Skateboarding World Championships in Boston and culminating this October with the Dew Tour Championships in Las Vegas, each event will feature "Innov8 Park", three separate Sony tents inviting fans to...

PARSIPPANY, N.J., May 26 /PRNewswire/ -- GSK Consumer Healthcare today announced it will update the alli product label to alert consumers to certain symptoms that have been associated with rare instances of severe liver injury reported in people taking orlistat, the active ingredient in alli. This update follows FDA's completion of its safety review of orlistat and is being implemented in conjunction with Roche, the manufacturer of the prescription dose of orlistat (Xenical). The agency...

SILVER SPRING, Md., May 26 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today advised consumers and health care professionals about potential rare occurrences of severe liver injury in patients taking the weight-loss medication orlistat, marketed as Xenical and Alli. (Logo: http://www.newscom.com/cgi-bin/prnh/20090824/FDALOGO ) The FDA has approved a revised label for the prescription drug Xenical. The agency is working with the manufacturer of Alli on label revisions...